MedPath
NMPA Approval

Omalizumab for Injection

国药准字S20240043

September 26, 2024

Drug Information

注射用奥马珠单抗

恩益坦

注射剂

150mg/瓶

生物制品

September 26, 2024

Company Information

Applicant Company

河北省石家庄市高新区仓盛路519号

Manufacturing Company

石家庄市高新区中山东路896号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.